Heart Failure Reviews

Papers
(The H4-Index of Heart Failure Reviews is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Biomarkers for the diagnosis and management of heart failure174
COVID-19 and myocarditis: a systematic review and overview of current challenges125
Polypharmacy definition and prevalence in heart failure: a systematic review52
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments51
SGLT2-inhibitors; more than just glycosuria and diuresis51
Mechanisms of COVID-19-induced heart failure: a short review50
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets48
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness40
Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress36
Resistance training in heart failure patients: a systematic review and meta-analysis32
Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications32
Immunity and inflammation: the neglected key players in congenital heart disease?31
Multiple roles of cardiac macrophages in heart homeostasis and failure31
Cardiogenic shock and acute kidney injury: the rule rather than the exception30
Current and emerging drug targets in heart failure treatment30
Ventricular non-compaction review29
A meta-analysis of microRNA expression profiling studies in heart failure27
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases27
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications27
Left ventricular hypertrophy and sudden cardiac death25
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide24
SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism24
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions24
Machine learning and statistical methods for predicting mortality in heart failure23
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure23
Filamin C in cardiomyopathy: from physiological roles to DNA variants23
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg23
Cardiorenal syndrome: long road between kidney and heart23
0.020149946212769